Genpact
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 5 Sell calls were followed by a 5% average decline over the next quarter.
- Recent price momentum is +4.7% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 6.4% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 12.1x | Better than 70% |
| Forward P/E | 11.3x | Better than 71% |
| Price / Sales | 1.4x | Better than 69% |
| P/E vs own 5-yr range | 34th pctl | Better than 73% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.1% | Better than 47% |
| Net income CAGR (3Y) | 16.1% | Better than 68% |
| Free cash flow CAGR (3Y) | 23.0% | Better than 67% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 36.0% | Better than 42% |
| Operating margin | 15.0% | Better than 65% |
| Net margin | 10.9% | Better than 62% |
| Return on equity | 22.4% | Better than 81% |
| Return on invested capital | 14.5% | Better than 81% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 12.3% | Better than 92% |
| 6-month return | 31.5% | Better than 90% |
| 12-month return (ex latest month) | -6.5% | Better than 26% |
| Distance below 52-week high | 13.3% | Better than 76% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.7x | Better than 47% |
| Debt to assets | 30.2% | Better than 41% |
| Interest coverage | 10.9x | Better than 74% |
| Free cash flow / net income | 131.1% | Better than 58% |
Analyst View D+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 37.5% | Better than 20% |
| Upside to average target | 14.6% | Better than 22% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 40.84
- Open
- 41.34
- Day range
- 41.25 - 42.34
- Avg price
- 41.79
- Volume
- 1.77M
- Turnover
- 73.78M
- Turnover ratei
- 1.24%
- Volume ratioi
- 0.75
- Amplitudei
- 2.68%
- 52-week rangei
- 26.71 - 47.87
Valuation
- P/Ei
- 13.26
- P/E (TTM)i
- 12.10
- P/Bi
- 2.56
- EPSi
- 3.13
- Book value / shi
- 16.20
- Net profit
- 523.42M
- Net assets
- 2.71B
Share structure
- Market cap
- 6.94B
- Float capi
- 5.92B
- Shares out
- 167.23M
- Float sharesi
- 142.60M
Dividend & listing
- Div yield (TTM)i
- 1.77%
- Dividend (TTM)
- 0.73
- Listing date
- 1970-01-01
13.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+21.38M net over the window
Short interest
- Shares short
- 10.68M
- % of floati
- 6.39%
- Days to coveri
- 5.95
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Genpact (G)?
Genpact last traded at 41.50. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Genpact's market cap?
About 6.94B.
What is the P/E ratio of Genpact?
The trailing twelve-month P/E is 12.10, below its own 5-year average of 16.65 — in the middle of its historical range (34.13% percentile). See the Valuation tab for the full history.
Does Genpact pay a dividend?
Yes. The trailing dividend yield is 1.77%. The 2025 payout was up 11.5% from 2024. See the Dividends tab for the full payment history.
Is Genpact a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 47.57, which implies 14.6% upside from the current price. This is not investment advice.
What is Genpact's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Genpact a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Genpact discussion 0 comments